Last updated: 4 months ago
Telix Pharmaceuticals Q4 FY24 Report: Revenue Surpasses Expectations!
Discover how Telix Pharmaceuticals exceeded its FY24 revenue guidance with $142M in Q4. Insights on financial performance and investor engagement at the JP Morgan Healthcare Conference.